NCLH-Norwegian Cruise Line Holdings revises COVID vaccination & testing protocols

   August 8, 2022 ,   Cruise Industry

NCLH-Norwegian Cruise Line Holdings announced revisions to its SailSAFE health & safety protocols which further align the company to the broader travel, hospitality, and leisure industry worldwide.

Vaccinated passengers aged 12+ will no longer have any pre-cruise COVID-related protocols and the unvaccinated ones may board the ship with a negative COVID test taken within 72 hours prior to departure, subject to local regulations.

NCLH's policy goes into effect fleetwide (NCL-Norwegian, Oceania, RSSC-Regent Seven Seas) for all voyages that commence on/after September 3, 2022.

Requirements might differ for guests on voyages departing from/visiting destinations with specific local regulations, such as but not limited to Bermuda, Canada, and Greece.

NCLH continues to strongly recommend all passengers be up to date on vaccination protocols and test at their convenience before travel.

Norwegian Joy cruise ship

Key fleetwide protocols changes (subject to local regulations), effective September 3, include:

  • Vaccinated passengers aged 12/older will no longer have any pre-cruise COVID-related protocols
  • Unvaccinated passengers, aged 1/older, or those who can't/decline to provide proof of vaccination, will need to present a negative medically administered PCR/Antigen COVID test taken no more than 72 hours before boarding
  • Passengers aged 11/under will not be subject to vaccination requirements/testing protocols of any kind
  • Vaccinated passengers must meet the generally-accepted definition of “fully vaccinated” based on the destination they're embarking and/or sailing to and have to provide proof of vaccination.

Your personal data will be processed and information from your device (cookies, unique identifiers, and other device data) may be stored by, accessed by and shared with third party vendors, or used specifically by this site or app. Some vendors may process your personal data on the basis of legitimate interest, which you can object to by managing your options below. Look for a link at the bottom of this page or in our privacy policy where you can withdraw consent.